ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,376 | +26.2% | 2,753 | +22.4% | 0.00% | – |
| Q2 2023 | $44,668 | +30.5% | 2,249 | +12.5% | 0.00% | – |
| Q1 2023 | $34,224 | -9.4% | 1,999 | +4.0% | 0.00% | – |
| Q4 2022 | $37,795 | +1159.8% | 1,923 | +861.5% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 200 | -18.4% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 245 | -14.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 287 | -7.1% | 0.00% | – |
| Q4 2021 | $6,000 | -25.0% | 309 | +12.0% | 0.00% | – |
| Q3 2021 | $8,000 | -33.3% | 276 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 276 | -26.2% | 0.00% | – |
| Q1 2021 | $16,000 | +23.1% | 374 | +61.9% | 0.00% | – |
| Q4 2020 | $13,000 | +1200.0% | 231 | +645.2% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 31 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |